Polio Vaccine
Worldwide oral polio vaccine cessation strategy is presented
Published in Vaccine Weekly, August 16th, 2006
According to the article, "Once the eradication of wild poliovirus has been confirmed, the public health benefits of routine immunization with OPV will no longer outweigh the burden of disease either due to paralysis caused by OPV (vaccine associated paralytic polio), or by outbreaks caused by circulating vaccine-derived polioviruses. The eventual cessation of OPV use in routine immunization programs worldwide will become necessary to assure a lasting eradication of polio."
"As the world moves towards polio eradication and its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-08-16)
More Articles from Vaccine Weekly
- Avian Influenza Vaccine
Reverse-genetics-produced H5N1 bird flu vaccine protects ferrets - Candidiasis Vaccine
Vaccines show promise against disseminated and mucosal candidiasis - Chickenpox Vaccine
Live varicella vaccine benefits HIV-infected children with depressed CD4+ T cell counts - Polio Vaccine
Inactivated poliovirus vaccine derived from Sabin strains has been developed - Adenovirus Pathogenesis
Adenovirus type 2 and type 5 E1A genes are expressed at different levels - Adverse Drug Reaction
Chronic exposure of tumor cells to PD98059 decreased inhibitory effect - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
